Showing results (961-970 of 10,077) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|March 28, 2013
Understanding XPO1 target networks using systems biology and mathematical modelingIrfana Muqbil, Michael Kauffman, Sharon Shacham, et al.Current Pharmaceutical Design|March 28, 2013
Deciphering the systems biology of mTOR inhibition by integrative transcriptome analysisSophie Domhan, Christian Schwager, Quanxiang Wei, et al.Current Pharmaceutical Design|March 28, 2013
Differential network analysis in human cancer researchRyan Gill, Somnath Datta, Susmita DattaCurrent Pharmaceutical Design|March 28, 2013
Receptor to glutamate NMDA-type: the functional diversity of the nr1 isoforms and pharmacological propertiesMario Eduardo Flores-Soto, Verónica Chaparro-Huerta, Martha Escoto-Delgadillo, et al.Current Pharmaceutical Design|March 28, 2013
Concentration-dependent mechanisms of adverse drug reactions in epilepsyMarta Vázquez, Pietro Fagiolino, Eduardo L MariñoCurrent Pharmaceutical Design|March 28, 2013
β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's diseaseElena Kuznetsova, Reinhard SchliebsCurrent Pharmaceutical Design|March 28, 2013
Role of physical exercise as complementary treatment for epilepsy and other brain disordersRicardo Mario Arida, Fulvio Alexandre Scorza, Esper Abrão CavalheiroCurrent Pharmaceutical Design|March 28, 2013
Acetylome regulation by sirtuins in the brain: from normal physiology to aging and pathologyShaday MichanCurrent Pharmaceutical Design|March 30, 2013
Phylogenetic aspects of nucleobindin-2/nesfatin-1Haneesha Mohan, Suraj UnniappanCurrent Pharmaceutical Design|March 30, 2013
Cardiovascular and antidipsogenic effects of nesfatin-1Gina L C Yosten, Willis K SamsonPageof 1,008